Diclofenac Diethylamine

Paracetamol (325mg/500mg) and Chlorzoxazone (250mg) Tablets is a centrally acting skeletal muscle relaxant and analgesic combination. Chlorzoxazone inhibits multi-synaptic reflex arcs in the spinal cord and subcortical areas of the brain, relieving painful skeletal muscle spasms. Paracetamol acts centrally to alleviate associated pain and discomfort. Indicated for acute, painful musculoskeletal conditions, muscle spasms, lumbago, torticollis, and strain/sprain trauma.

Diclofenac Gel 1.16% (Diclofenac Diethylamine) is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Diclofenac Sodium/Potassium Tablets (50mg Gastro-Resistant, 75mg/100mg Prolonged Release) is an oral phenylacetic acid non-steroidal anti-inflammatory drug (NSAID) on the WHO Model List of Essential Medicines. It potently inhibits both cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes, halting prostaglandin synthesis, and also reduces intracellular concentrations of free arachidonic acid in leukocytes. Potassium salt provides rapid dissolution and quick pain relief; sodium prolonged-release provides steady 24-hour therapeutic coverage. Indicated for relief of pain and inflammation in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute musculoskeletal disorders, and acute migraine attacks.

Diclofenac Sodium/Potassium Tablets (50mg Gastro-Resistant, 75mg/100mg Prolonged Release) is an oral phenylacetic acid non-steroidal anti-inflammatory drug (NSAID) on the WHO Model List of Essential Medicines. It potently inhibits both cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes, halting prostaglandin synthesis, and also reduces intracellular concentrations of free arachidonic acid in leukocytes. Potassium salt provides rapid dissolution and quick pain relief; sodium prolonged-release provides steady 24-hour therapeutic coverage. Indicated for relief of pain and inflammation in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute musculoskeletal disorders, and acute migraine attacks.

Diclofenac Sodium Injection (25mg/ml, 75mg/3ml) is a parenteral phenylacetic acid NSAID on the WHO Model List of Essential Medicines. It potently inhibits COX-1 and COX-2 enzymes to block prostaglandin synthesis. Indicated for acute severe pain, renal colic, biliary colic, acute postoperative pain, and severe trauma.

Diclofenac Sodium/Potassium Tablets (50mg Gastro-Resistant, 75mg/100mg Prolonged Release) is an oral phenylacetic acid non-steroidal anti-inflammatory drug (NSAID) on the WHO Model List of Essential Medicines. It potently inhibits both cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes, halting prostaglandin synthesis, and also reduces intracellular concentrations of free arachidonic acid in leukocytes. Potassium salt provides rapid dissolution and quick pain relief; sodium prolonged-release provides steady 24-hour therapeutic coverage. Indicated for relief of pain and inflammation in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute musculoskeletal disorders, and acute migraine attacks.

Paracetamol / Acetaminophen (Tablets 500mg, 650mg, 1000mg; Oral Suspension 120mg, 125mg, 250mg per 5ml; Drops 100mg/ml) is a first-line non-opioid analgesic and antipyretic on the WHO Model List of Essential Medicines. It selectively inhibits central prostaglandin synthesis through peroxidase-dependent inhibition of COX enzymes in the brain and spinal cord, activates descending serotonergic inhibitory pathways, and resets the hypothalamic thermoregulatory center to reduce fever through cutaneous vasodilation and sweating. Unlike NSAIDs, it does NOT inhibit peripheral cyclooxygenase, causing zero gastric mucosal ulceration, platelet dysfunction, or renal vasoconstriction. Indicated as first-line therapy for mild-to-moderate pain (headache, toothache, dysmenorrhea, osteoarthritis) and fever of diverse etiologies.

Diclofenac 1.16%, Linceed Oil 3%, Methyl Salicylate 10% and Menthol 5% Gel is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Paracetamol / Acetaminophen (Tablets 500mg, 650mg, 1000mg; Oral Suspension 120mg, 125mg, 250mg per 5ml; Drops 100mg/ml) is a first-line non-opioid analgesic and antipyretic on the WHO Model List of Essential Medicines. It selectively inhibits central prostaglandin synthesis through peroxidase-dependent inhibition of COX enzymes in the brain and spinal cord, activates descending serotonergic inhibitory pathways, and resets the hypothalamic thermoregulatory center to reduce fever through cutaneous vasodilation and sweating. Unlike NSAIDs, it does NOT inhibit peripheral cyclooxygenase, causing zero gastric mucosal ulceration, platelet dysfunction, or renal vasoconstriction. Indicated as first-line therapy for mild-to-moderate pain (headache, toothache, dysmenorrhea, osteoarthritis) and fever of diverse etiologies.

Diclofenac Dithylamine 1.16%, Linseed Oil 3%, Methyl Salicylate 10% and Menthol 5% Spray is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Diclofenac Diethylamine / Sodium Formulations (1.16%-2% Gel, Spray, and 200mg Transdermal Patch with Methyl Salicylate, Menthol, Linseed/Sesame Oil, or Thiocolchicoside) is a targeted topical analgesic and anti-inflammatory formulation. Diclofenac penetrates through the stratum corneum directly into underlying joints, tendons, and muscles, inhibiting local COX-2 and prostaglandin production with minimal systemic plasma concentrations (<1-2% of oral levels). Methyl salicylate and menthol provide counterirritant distraction and cooling relief; linseed oil delivers alpha-linolenic acid to reduce local swelling. Indicated for localized joint pain in osteoarthritis (knees, hands), acute muscle strains, sprains, backache, and sports trauma.

Diclofenac Sodium/Potassium Tablets (50mg Gastro-Resistant, 75mg/100mg Prolonged Release) is an oral phenylacetic acid non-steroidal anti-inflammatory drug (NSAID) on the WHO Model List of Essential Medicines. It potently inhibits both cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes, halting prostaglandin synthesis, and also reduces intracellular concentrations of free arachidonic acid in leukocytes. Potassium salt provides rapid dissolution and quick pain relief; sodium prolonged-release provides steady 24-hour therapeutic coverage. Indicated for relief of pain and inflammation in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute musculoskeletal disorders, and acute migraine attacks.

Diclofenac Sodium/Potassium Tablets (50mg Gastro-Resistant, 75mg/100mg Prolonged Release) is an oral phenylacetic acid non-steroidal anti-inflammatory drug (NSAID) on the WHO Model List of Essential Medicines. It potently inhibits both cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes, halting prostaglandin synthesis, and also reduces intracellular concentrations of free arachidonic acid in leukocytes. Potassium salt provides rapid dissolution and quick pain relief; sodium prolonged-release provides steady 24-hour therapeutic coverage. Indicated for relief of pain and inflammation in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute musculoskeletal disorders, and acute migraine attacks.

Diclofenac Sodium/Potassium Tablets (50mg Gastro-Resistant, 75mg/100mg Prolonged Release) is an oral phenylacetic acid non-steroidal anti-inflammatory drug (NSAID) on the WHO Model List of Essential Medicines. It potently inhibits both cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes, halting prostaglandin synthesis, and also reduces intracellular concentrations of free arachidonic acid in leukocytes. Potassium salt provides rapid dissolution and quick pain relief; sodium prolonged-release provides steady 24-hour therapeutic coverage. Indicated for relief of pain and inflammation in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute musculoskeletal disorders, and acute migraine attacks.

Chlorhexidine Gluconate 1% , Metronidazole 1% and Lidocaine 2% dental Gel is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Diclofenac Sodium Suppositories (100mg) is a rectal formulation on the WHO Model List of Essential Medicines. Rectal absorption bypasses gastric mucosal contact, providing effective systemic anti-inflammatory and analgesic action. Indicated for post-operative orthopedic pain, severe arthritis flares, and acute pain in patients unable to take oral medication.

Hydrocortisone Acetate (1% w/w) is a low-potency (Class VII) topical corticosteroid on the WHO Model List of Essential Medicines. It represents the safest topical steroid for sensitive skin areas (face, intertriginous skin folds, groin) and pediatric patients, providing anti-inflammatory, anti-pruritic, and mild vasoconstrictive actions with minimal risk of skin thinning or systemic absorption. Indicated for mild eczema, facial dermatitis, intertrigo, insect bites, and anogenital pruritus.

Diclofenac Diethylamine / Sodium Formulations (1.16%-2% Gel, Spray, and 200mg Transdermal Patch with Methyl Salicylate, Menthol, Linseed/Sesame Oil, or Thiocolchicoside) is a targeted topical analgesic and anti-inflammatory formulation. Diclofenac penetrates through the stratum corneum directly into underlying joints, tendons, and muscles, inhibiting local COX-2 and prostaglandin production with minimal systemic plasma concentrations (<1-2% of oral levels). Methyl salicylate and menthol provide counterirritant distraction and cooling relief; linseed oil delivers alpha-linolenic acid to reduce local swelling. Indicated for localized joint pain in osteoarthritis (knees, hands), acute muscle strains, sprains, backache, and sports trauma.

Janaushadhi Burn Relief Spray (Lidocaine 3% and Benzethonium 0.20% Spray) is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.

Diclofenac Diethylamine / Sodium Formulations (1.16%-2% Gel, Spray, and 200mg Transdermal Patch with Methyl Salicylate, Menthol, Linseed/Sesame Oil, or Thiocolchicoside) is a targeted topical analgesic and anti-inflammatory formulation. Diclofenac penetrates through the stratum corneum directly into underlying joints, tendons, and muscles, inhibiting local COX-2 and prostaglandin production with minimal systemic plasma concentrations (<1-2% of oral levels). Methyl salicylate and menthol provide counterirritant distraction and cooling relief; linseed oil delivers alpha-linolenic acid to reduce local swelling. Indicated for localized joint pain in osteoarthritis (knees, hands), acute muscle strains, sprains, backache, and sports trauma.

Diclofenac Diethylamine / Sodium Formulations (1.16%-2% Gel, Spray, and 200mg Transdermal Patch with Methyl Salicylate, Menthol, Linseed/Sesame Oil, or Thiocolchicoside) is a targeted topical analgesic and anti-inflammatory formulation. Diclofenac penetrates through the stratum corneum directly into underlying joints, tendons, and muscles, inhibiting local COX-2 and prostaglandin production with minimal systemic plasma concentrations (<1-2% of oral levels). Methyl salicylate and menthol provide counterirritant distraction and cooling relief; linseed oil delivers alpha-linolenic acid to reduce local swelling. Indicated for localized joint pain in osteoarthritis (knees, hands), acute muscle strains, sprains, backache, and sports trauma.

Diclofenac Diethylamine / Sodium Formulations (1.16%-2% Gel, Spray, and 200mg Transdermal Patch with Methyl Salicylate, Menthol, Linseed/Sesame Oil, or Thiocolchicoside) is a targeted topical analgesic and anti-inflammatory formulation. Diclofenac penetrates through the stratum corneum directly into underlying joints, tendons, and muscles, inhibiting local COX-2 and prostaglandin production with minimal systemic plasma concentrations (<1-2% of oral levels). Methyl salicylate and menthol provide counterirritant distraction and cooling relief; linseed oil delivers alpha-linolenic acid to reduce local swelling. Indicated for localized joint pain in osteoarthritis (knees, hands), acute muscle strains, sprains, backache, and sports trauma.

Diclofenac Sodium (50mg) and Thiocolchicoside (4mg/8mg) Tablets combines a potent NSAID with a central non-sedating muscle relaxant. Relieves pain, inflammation, and muscle contracture in acute lumbago, torticollis, sprains, and spinal radiculopathies.

Diclofenac Sodium (50mg) and Thiocolchicoside (4mg/8mg) Tablets combines a potent NSAID with a central non-sedating muscle relaxant. Relieves pain, inflammation, and muscle contracture in acute lumbago, torticollis, sprains, and spinal radiculopathies.

Diclofenac Sodium/Potassium Tablets (50mg Gastro-Resistant, 75mg/100mg Prolonged Release) is an oral phenylacetic acid non-steroidal anti-inflammatory drug (NSAID) on the WHO Model List of Essential Medicines. It potently inhibits both cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes, halting prostaglandin synthesis, and also reduces intracellular concentrations of free arachidonic acid in leukocytes. Potassium salt provides rapid dissolution and quick pain relief; sodium prolonged-release provides steady 24-hour therapeutic coverage. Indicated for relief of pain and inflammation in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute musculoskeletal disorders, and acute migraine attacks.

Tramadol Hydrochloride (50mg immediate-release) and Diclofenac Sodium (75mg sustained-release) Tablets combines a centrally acting dual-mechanism opioid with a potent peripheral non-steroidal anti-inflammatory drug (NSAID). Tramadol dampens central pain transmission via mu-opioid activation and monoaminergic reuptake inhibition; diclofenac blocks peripheral COX-1 and COX-2 enzymes to eliminate tissue inflammation and prostaglandin-mediated sensitization of nociceptors. Indicated for severe acute and chronic musculoskeletal pain, post-surgical orthopedic pain, and severe osteoarthritic/rheumatoid joint destruction.